Gómez-Aguado, I.; Rodríguez-Castejón, J.; Beraza-Millor, M.; Vicente-Pascual, M.; Rodríguez-Gascón, A.; Garelli, S.; Battaglia, L.; del Pozo-Rodríguez, A.; Solinís, M.Á.
mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics 2021, 13, 1472.
https://doi.org/10.3390/pharmaceutics13091472
AMA Style
Gómez-Aguado I, Rodríguez-Castejón J, Beraza-Millor M, Vicente-Pascual M, Rodríguez-Gascón A, Garelli S, Battaglia L, del Pozo-Rodríguez A, Solinís MÁ.
mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics. 2021; 13(9):1472.
https://doi.org/10.3390/pharmaceutics13091472
Chicago/Turabian Style
Gómez-Aguado, Itziar, Julen Rodríguez-Castejón, Marina Beraza-Millor, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Sara Garelli, Luigi Battaglia, Ana del Pozo-Rodríguez, and María Ángeles Solinís.
2021. "mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation" Pharmaceutics 13, no. 9: 1472.
https://doi.org/10.3390/pharmaceutics13091472
APA Style
Gómez-Aguado, I., Rodríguez-Castejón, J., Beraza-Millor, M., Vicente-Pascual, M., Rodríguez-Gascón, A., Garelli, S., Battaglia, L., del Pozo-Rodríguez, A., & Solinís, M. Á.
(2021). mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics, 13(9), 1472.
https://doi.org/10.3390/pharmaceutics13091472